Mark E. Prince
Impact in
- Otorhinolaryngology top 0.05%
- Head and Neck Cancer Studies
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Papers in
-
- Head and Neck Cancer Studies 90
- Oncology 63
- Cancer Cells and Metastasis 26
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Gregory T. Wolf (84 shared papers)Carol Rossier Bradford (109 shared papers)Douglas Brian Chepeha (76 shared papers)Thomas E. Carey (64 shared papers)Laurie Ailles (4 shared papers)Avraham Eisbruch (56 shared papers)Francis Paul Worden (60 shared papers)Theodoros Nicholas Teknos (26 shared papers)
- Journals
- Head & Neck (37 papers)Otolaryngology (23 papers)International Journal of Radiation Oncology*Biology*Physics (19 papers)Oral Oncology (17 papers)Cell Reports (12 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark E. Prince
283 papers receiving 31.6k citations
Mark E. Prince's Hit Papers
Peers
Comparison fields: 5 of 179
- Otorhinolaryngology 4.0k
- Cancer Research 8.1k
- Oncology 8.9k
- Molecular Biology 13.5k
- Pulmonary and Respiratory Medicine 4.8k
Countries citing papers authored by Mark E. Prince
This map shows the geographic impact of Mark E. Prince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Prince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Prince more than expected).
Fields of papers citing papers by Mark E. Prince
This network shows the impact of papers produced by Mark E. Prince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Prince. The network helps show where Mark E. Prince may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Prince, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 295 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 2 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 3 | Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Hit paper breakdown → | 2007 | 1848 |
| 4 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
| 5 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1714 |
| 6 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 7 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 810 |
| 8 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 749 |
| 9 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 685 |
| 10 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 606 |
| 11 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 583 |
| 12 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 569 |
| 13 | EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer Hit paper breakdown → | 2008 | 521 |
| 14 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers Hit paper breakdown → | 2018 | 456 |
| 15 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers Hit paper breakdown → | 2018 | 451 |
| 16 | The Immune Landscape of Cancer Hit paper breakdown → | 2019 | 449 |
| 17 | Tissue invasion and metastasis: Molecular, biological and clinical perspectives Hit paper breakdown → | 2015 | 409 |
| 18 | 2018 | 392 | |
| 19 | 2010 | 388 | |
| 20 | 2004 | 386 |
About Mark E. Prince
Mark E. Prince is a scholar working on Otorhinolaryngology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 295 papers that have together received 32.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (90 papers), Cancer Genomics and Diagnostics (27 papers), Cancer Cells and Metastasis (26 papers), Reconstructive Surgery and Microvascular Techniques (16 papers), Cancer Immunotherapy and Biomarkers (11 papers), Tracheal and airway disorders (10 papers), Immunotherapy and Immune Responses (10 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Otorhinolaryngology (4.0k citations), Cancer Research (8.1k citations), Oncology (8.9k citations), Molecular Biology (13.5k citations) and Pulmonary and Respiratory Medicine (4.8k citations). Mark E. Prince has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Gregory T. Wolf, Carol Rossier Bradford, Douglas Brian Chepeha, Thomas E. Carey, Laurie Ailles, Avraham Eisbruch, Francis Paul Worden, Theodoros Nicholas Teknos, Michael J. Kaplan and Irving L. Weissman. Their work appears in journals such as Head & Neck, Otolaryngology, International Journal of Radiation Oncology*Biology*Physics, Oral Oncology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.